The aim of this symposium is to discuss the impact of poor treatment and poor inhaler technique on asthma outcomes. In addition, the symposium will…

Chronic obstructive pulmonary disease (COPD) is a major health issue worldwide, with disease burden, healthcare costs, and mortality rates all…

Inhalation therapy remains the cornerstone of treatment for bronchial diseases. Despite being pharmacologically efficacious, currently available inhaled…

Emphysema is a progressive, debilitating disease characterised by irreversible destruction of lung tissue. The gas trapping within the destroyed alveoli…

Chronic obstructive pulmonary disease (COPD) is often accompanied by other chronic diseases associated with systemic inflammation, such as chronic heart…

In the development of new antiallergic or antiasthmatic therapies, mouse models have helped to identify novel therapeutic agents. Before a medication is…

Asthma is a common disease among pregnant women. Uncontrolled asthma may increase the risk of maternal and foetal complications, thus optimal asthma…

The component-resolved diagnosis use in routine clinical and laboratory practice has increased in recent years. Recombinant allergens can be produced…

Idiopathic pulmonary fibrosis (IPF) is the most common and most lethal fibrosing interstitial pneumonia, with a mortality rate that exceeds that of many…

Pulmonary alveolar proteinosis (PAP) is a diffuse pulmonary disease, characterised by the accumulation of lipoproteinaceous material in the distal air…